Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients
Clinical trial NCT03278015 · UNKNOWN
Trial details
- NCT number
- NCT03278015
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-01
- Primary completion
- 2018-03-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.